5/24/2022 1:05:53 AM
Genentech To Present Data From Trials Of 18 Approved And Investigational Medicines Across More Than 20 Cancer Types
5/11/2022 1:13:48 AM
Genentech Says Phase III SKYSCRAPER-01 Study In PD-L1-High Metastatic Non-Small Cell Lung Cancer Fails
5/10/2022 1:19:53 AM
Roche Extends Commitment To WFH Humanitarian Aid Program Until The End Of 2028
4/29/2022 1:09:12 AM
Roche Announces New Three-year Data From FIREFISH Study
4/29/2022 1:06:52 AM
Three-Year Data For Genentech's Evrysdi Show Long-Term
Improvements In Survival In Babies With Type 1 SMA
4/25/2022 1:04:21 AM
Roche Q1 Group Sales Up 11% To CHF 16.4 Bln
4/5/2022 1:08:11 AM
Roche To Showcase Future Of Diagnostic Solutions At EuroMedLab, 10 To 14 April 2022 Munich
4/4/2022 1:10:37 AM
Genentech Says New Data Ocrevus Show Benefit In Disability Progression And Cognitive Decline In PPMS
4/4/2022 1:08:39 AM
Genentech Says FDA Grants Priority Review For Actemra Intravenous For COVID-19 In Hospitalized Adults
3/30/2022 1:07:15 AM
Roche Says Phase 3 SKYSCRAPER-02 Study Did Not Meet Co-primary Endpoint Of Progression-free Survival
3/25/2022 8:57:02 AM
Roche: CHMP Recommends EU Approval Of Polivy Combination For Untreated Diffuse Large B-cell Lymphoma
3/25/2022 2:10:28 AM
Genentech To Present Data Across Broad And Impactful Neuroscience Portfolio At 2022 AAN Annual Meeting